Radiant Sage Adds Event Adjudication Committee Solution
Radiant Sage, a provider of on-demand clinical trial imaging infrastructure solutions, announced its Event Adjudication Committee (EAC) solution for its RadClinica Clinical Trial Management System (CTMS).
Radiant Sage, a provider of on-demand clinical trial imaging infrastructure solutions, announced its Event Adjudication Committee (EAC) solution for its RadClinica Clinical Trial Management System (CTMS). The new module provides an electronic solution to automate the event adjudication process.
The EAC solution will be offered as an add-on module to customize workflows and quality assurance based on specific types of events. It acquires the required documentation (including images) associated to each event, verifies that the necessary data has been uploaded, initiates the QA review tasks (i.e. redactions, translation), and then enables project managers to create the review package. The system offers management and reporting tools to provide the entire clinical team oversight of the process.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Ethical, Biosafety, and Scientific Review Considerations in Hematology and Oncology Clinical Trials
September 10th 2024The current oncology and hematology drug development pipeline features a wide array of large molecule therapeutics. As a result, clinical trial protocols have grown more complex, requiring sponsors, CROs, and research sites to tackle a variety of challenges that were less common with older, more traditional therapies.
